The Drug-Induced Respiratory Disease Website
Or 'ILD'. (Fr: PnP subaiguë). A.k.a. pulmonary infiltrates. Generally bilateral and symmetrical. Gradual onset. Consistent with but not specific for an NSIP-c pattern on pathology. Less- dense, severe, acute and diffuse than pattern Ia. Lacks the features of ARDS that may accompany pattern Ia. Can be in the form of disseminated linear, reticulonodular, miliary or patchy opacities. BAL is indicated to separate this pattern from PIE (Ic) or DAH (IIIa). Acute chest pain can be at the forefront. A search for microorganisms including Pneumocystis (stains, PCR) is indicated. On pathology (although not many cases undergo a confirmatory lung biopsy), there is interstitial inflammation and a more or less dense cellular interstitial cellular infiltrate (NSIP-c). Fibrosis, alveolar edema and/or a reactive epithelium denote those cases resulting from with antineoplastic chemotherapy agents. The frontier between patterns Ia and I b can be difficult to draw, so please check drugs under both Ia and Ib. Patients may quickly shift from pattern Ib to Ia particularly if the the causal drug is inappropriately continued. Prompt withdrawal must be considered, underlying disease permitting, and can be therapeutic.
Publications
Acute amiodarone pulmonary toxicity in the form of organizing pneumonia triggered by orthotopic heart transplantation.
Respiratory medicine case reports 2021;34;101532 — 2021 — 101532
Amiodarone-induced pulmonary toxicity: case study with syndrome analysis.
Heart & lung : the journal of critical care 2013 Jul-Aug;42;262-6 — 2013 Jul-Aug — 262-6
Amiodarone-induced pulmonary toxicity.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2012 Oct 16;184;E819 — 2012 Oct 16 — E819
Possible association of pneumonitis with amiodarone therapy.
American heart journal 1980 Sep;100;412-3 — 1980 Sep — 412-3